Quest Diagnostics (DGX) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $0.78.
- Quest Diagnostics' Debt to Equity fell 1486.45% to $0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.78, marking a year-over-year decrease of 1486.45%. This contributed to the annual value of $0.91 for FY2024, which is 2279.23% up from last year.
- According to the latest figures from Q3 2025, Quest Diagnostics' Debt to Equity is $0.78, which was down 1486.45% from $0.78 recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Debt to Equity ranged from a high of $0.91 in Q3 2024 and a low of $0.59 during Q1 2021
- Over the past 5 years, Quest Diagnostics' median Debt to Equity value was $0.67 (recorded in 2022), while the average stood at $0.71.
- Per our database at Business Quant, Quest Diagnostics' Debt to Equity plummeted by 1650.83% in 2021 and then skyrocketed by 3895.53% in 2024.
- Over the past 5 years, Quest Diagnostics' Debt to Equity (Quarter) stood at $0.62 in 2021, then increased by 8.45% to $0.67 in 2022, then rose by 10.72% to $0.74 in 2023, then grew by 22.79% to $0.91 in 2024, then dropped by 14.75% to $0.78 in 2025.
- Its Debt to Equity stands at $0.78 for Q3 2025, versus $0.78 for Q2 2025 and $0.84 for Q1 2025.